Loading...
IL-37 is highly expressed in T(reg) cells of melanoma patients and enhanced by melanoma cell secretome
Immune suppression is one of the 10 hallmarks of cancer. Interleukin-37 (IL-37), a member of the IL-1 family, inhibits both innate and adaptive immunity, and has been shown to modulate immune responses in various disease conditions. Yet, IL-37 has rarely been investigated in cancer patients, and its...
Saved in:
| Published in: | Mol Carcinog |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6692223/ https://ncbi.nlm.nih.gov/pubmed/31099111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.23044 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|